Teradyne Stock 2026: Bull & Bear Price Targets

Teradyne (NASDAQ: TER) enters 2026 carrying two competing narratives: the promise of AI chip testing as a structural growth driver, and the persistent threat of semiconductor cycle timing risk as a check on that optimism. For investors holding or evaluating TER, neither reflexive optimism nor blanket caution produces a useful analytical framework. This analysis builds both scenarios from the ground up, with named catalysts, named risks, price target ranges, and the conditions that determine which path plays out.

Teradyne stock forecasts for 2026 span a wide range. In the bull case, TER could reach $135–$160 if AI chip test demand accelerates alongside a broad semiconductor upcycle recovery and Universal Robots returns to growth. The base case, anchored by Wall Street consensus estimates, sits near $105–$120. In the bear case, if the upcycle stalls and key risks converge, TER could retreat toward $65–$80, representing material downside from current levels.

This article is for informational purposes only and does not constitute financial advice. Investing in stocks involves risk, including the potential loss of principal. Past performance is not indicative of future results. Please consult a licensed financial advisor before making investment decisions.

Table 1: Teradyne Company Snapshot

Data as of mid-2025. Verify current figures before making any investment decision.

Contents

• What Does Teradyne Do? Business Model and Segments
• The Semiconductor Cycle in 2025–2026: Setting the Stage for TER
• The Bull Case for Teradyne Stock in 2026
• The Bear Case for Teradyne Stock in 2026
• Teradyne Valuation: Is TER Stock Cheap or Expensive?
• What Wall Street Analysts Are Saying About TER Stock
• Teradyne's Competitive Position: How TER Stacks Up Against Advantest
• Teradyne Stock 2026 Scenario Summary: Bull, Base, and Bear Price Targets
• Verdict: Is Teradyne Stock a Buy, Hold, or Sell for 2026?
• Frequently Asked Questions: Teradyne Stock 2026

What Does Teradyne Do? Business Model and Segments

Teradyne (NASDAQ: TER) is a North Reading, Massachusetts-based technology company that designs and manufactures automated test equipment (ATE) for semiconductors and collaborative robots for industrial automation. Founded in 1960, TER operates four business segments: Semiconductor Test, Industrial Automation, Wireless Test, and System Test. Its largest segment, Semiconductor Test, accounts for approximately 65–70% of total revenue.

Table 2: Teradyne Segment Revenue Breakdown

Source: Teradyne annual filings. Percentages approximate; verify against most recent 10-K.

Semiconductor Test: The Revenue Engine

Teradyne's Semiconductor Test segment generates the bulk of company revenue through sales of automated test equipment (ATE), meaning machines that automatically verify chips work correctly before they leave the factory. As chipmakers manufacture increasingly complex semiconductors, each chip requires longer and more thorough test routines. This dynamic, called test intensity, is the foundational mechanism behind TER's bull thesis: greater chip complexity translates directly into more ATE revenue per chip produced.

Teradyne's flagship ATE platform is the UltraFLEX system, designed to handle the most demanding test requirements for logic chips, memory, and AI accelerators. TER holds the leading global market share in system-on-chip (SoC) test and competes primarily against Advantest Corporation (TYO: 6857) across ATE product categories. Teradyne is not an AI chip maker. It makes the equipment that tests AI chips, positioning it as an infrastructure-layer beneficiary of AI capex growth.

Industrial Automation: Universal Robots and MiR

Teradyne acquired Universal Robots (UR) in 2015 for approximately $285 million, making it the world's leading manufacturer of collaborative robots (cobots): robotic arms designed to work safely alongside human workers, unlike traditional industrial robots that operate in isolated cages. UR serves manufacturing, logistics, and electronics assembly customers across more than 60 countries, with the global cobot and autonomous mobile robot (AMR) market representing a multi-billion dollar addressable opportunity.

The Industrial Automation segment also includes Mobile Industrial Robots (MiR), acquired in 2018, which produces autonomous mobile robots for warehouse and factory floor logistics. UR and MiR together contribute approximately 20–25% of TER's total revenue, making this segment a meaningful swing factor in the 2026 outlook alongside semiconductor test.

The Semiconductor Cycle in 2025–2026: Setting the Stage for TER

As of mid-2025, the semiconductor equipment cycle appears to be in early-to-mid recovery, with AI chip demand leading and consumer electronics and industrial segments showing more gradual improvement. This recovery position shapes every aspect of the 2026 forecast for Teradyne, because TER's revenue tracks semiconductor capital expenditure patterns with unusual precision.

How the Semiconductor Cycle Drives TER Revenue

The semiconductor industry moves through boom-and-bust inventory cycles. In an upcycle, chip demand exceeds supply. Chipmakers invest heavily in new fabrication capacity and test equipment to meet that demand, generating strong ATE order intake for Teradyne. In a downcycle, demand falls or chip inventories accumulate. Manufacturers cut capex sharply, and ATE orders drop. The magnitude of these swings is significant: in upcycle years, TER revenue can surge 20–30% year-over-year; in downcycle years, it can contract by similar magnitudes.

This cyclicality makes Teradyne a high-beta play within the semiconductor equipment space. Understanding where the cycle stands entering 2026 is prerequisite to evaluating either the bull or the bear case with any credibility.

The 2023–2024 Inventory Correction: What Happened and Why It Matters

Following a period of elevated chip demand in 2021–2022, semiconductor manufacturers over-ordered components. By 2023, excess inventory had accumulated across the supply chain. Chipmakers responded by sharply reducing capex on new equipment, including ATE. Teradyne's revenue declined materially during this correction period, and TER's stock price reflected that pressure. This is the primary reason Teradyne stock fell sharply from its 2021–2022 peak.

The 2026 forecast hinges on how completely and quickly the recovery from this downcycle is unfolding. Apple (NASDAQ: AAPL), a major TER customer through its custom chip supply chain, continues to increase chip complexity with each product generation, providing a demand baseline that anchors TER's ATE business through cycle turns. Entering 2026, FY2025 revenue is tracking toward approximately $2.8–3.0 billion based on available consensus estimates, with EPS recovery underway from the trough. These figures form the baseline from which the 2026 scenarios are projected.

The Bull Case for Teradyne Stock in 2026

In the bull case, Teradyne stock could reach $135–$160 by the end of 2026, driven by three converging tailwinds: AI chip test demand, a broadening semiconductor upcycle, and Universal Robots recovery. This target range implies approximately 40–65% upside from the ~$97 level where TER traded in mid-2025.

If AI capex sustains and the semiconductor upcycle recovery matches market expectations through 2026, TER could reach $135–$160, supported by revenue growth of 20–30% and meaningful P/E multiple expansion on top of earnings recovery.

Catalyst #1: AI and HBM Chip Testing Demand Surge

The most structurally differentiated bull catalyst for Teradyne is its exposure to the AI chip testing market. Teradyne is not an AI company, but it sits at a critical infrastructure layer in the AI supply chain: it makes the machines that test AI chips.

AI accelerator chips (such as NVIDIA's (NASDAQ: NVDA) H100, H200, and Blackwell-class GPUs) are among the most complex semiconductors ever manufactured. Complexity drives test intensity: as chips grow more complex, they require longer test routines, increasing the revenue Teradyne earns per chip tested. The supply chain works as follows: AI capex spending drives GPU manufacturing volume at TSMC and other fabs, which drives demand for Teradyne's ATE systems to validate those chips before they ship.

High Bandwidth Memory (HBM), a stacked memory architecture used in AI chips to enable fast data access, is among the most test-intensive semiconductor products manufactured today. HBM's 3D-stacked architecture requires rigorous test procedures that ATE systems must perform at high throughput. Major HBM producers including SK Hynix and Micron, which supply NVIDIA's AI accelerator ecosystem, represent a high-value market segment for TER's ATE business.

If AI hyperscaler capex sustains through 2026, Teradyne's UltraFLEX platform could capture a disproportionate share of the resulting ATE order growth. The bull case implies ATE revenue growing 20–30% year-over-year in 2026, potentially supporting total company revenue of $3.4–3.8 billion.

In the bull case, free cash flow (FCF), the cash a company generates after paying for its operating expenses and capital investments, could recover to $600–800 million annually during a strong upcycle year. Strong FCF funds both the quarterly dividend and an active share repurchase program, providing EPS accretion through buybacks on top of organic earnings growth.

Catalyst #2: Broad Semiconductor Upcycle Acceleration

The AI test opportunity does not stand alone. A full semiconductor upcycle benefits all of Teradyne's ATE product lines simultaneously, not only AI-related chips.

Consumer electronics SoCs (smartphones, tablets, PCs), automotive chips, analog semiconductors, and industrial chips all contribute ATE demand that flows to TER alongside AI. If the 2025 recovery accelerates into a broad capex upcycle through 2026, Teradyne's semiconductor test order book could grow across every end market, not just the AI segment. This revenue diversification within the bull case makes the thesis more resilient than an AI-only story.

If consensus ATE revenue estimates for 2026 prove too conservative, which is plausible if upcycle momentum accelerates, estimate revisions upward typically drive meaningful stock re-rating for semiconductor equipment companies.

Catalyst #3: Universal Robots Recovery

UR represents a distinct second growth engine in the bull case. Universal Robots faced a pronounced industrial slowdown during 2023–2024 as global manufacturing capex contracted. UR's growth decelerated from double-digit rates to near-flat.

If manufacturing capex recovers through 2025–2026 and cobot adoption continues its secular expansion, UR could return to double-digit revenue growth. The global cobot market is projected to grow at a compound annual growth rate in the mid-teens through the late 2020s, driven by labor cost pressures, nearshoring of manufacturing, and expanding use cases in electronics assembly and logistics. A UR recovery returning to 15–20% annual growth would add approximately $80–120 million in revenue growth on top of the semiconductor test recovery, supporting a valuation re-rating as TER establishes itself as a genuine two-engine growth company.

Catalyst #4: Apple Chip Complexity and Capital Returns

Apple (NASDAQ: AAPL) is Teradyne's largest single ATE customer, purchasing test equipment to validate its A-series iPhone chips, M-series Mac chips, and custom modems manufactured through TSMC and other partners. Each new Apple silicon generation increases chip complexity, which increases the amount of ATE time required to validate each device before shipping.

Apple's continued investment in custom silicon across all product categories sustains strong ATE demand from its supply chain. Combined with FCF-funded buybacks reducing share count and amplifying EPS growth, Apple's chip pipeline provides a demand floor that makes the bull case more durable than a pure AI bet.

The Bear Case for Teradyne Stock in 2026

In the bear case, Teradyne stock could fall to $65–$80 by the end of 2026 if key risks converge, representing 18–33% downside from mid-2025 levels.

A semiconductor cycle timing miss in 2026 could trigger both earnings estimate cuts and multiple compression simultaneously, creating a double-bear scenario that puts TER near $65–$80, or potentially lower if AI capex also disappoints.

Risk #1: Semiconductor Cycle Timing Miss

The most structural bear risk for Teradyne is not a permanent business deterioration but a cycle timing miss. If the semiconductor upcycle recovery peaks in late 2025 or delays to back-half 2026 or 2027, the consensus revenue and EPS estimates that underpin TER's current valuation prove too optimistic.

The 2023–2024 downcycle provides a direct precedent. Consensus estimates for TER were revised downward multiple times in 2023 as the inventory correction proved deeper and longer than analysts initially modeled. A similar timing disappointment in 2026 could trigger a sequence of estimate cuts that de-rate the stock before the recovery reasserts. The key signal to watch: ATE order intake trends in Q1–Q2 2026. Softening orders would be an early warning of this scenario materializing.

If 2026 revenue comes in at $2.6–2.8 billion, below the consensus of approximately $3.2–3.5 billion, EPS could land at $3.00–3.50 per share versus the bull case expectation of $5.00+, compressing both the earnings base and the multiple investors apply to it.

Risk #2: AI Capex Deceleration or Test Efficiency Improvements

The AI chip testing bull thesis rests on two assumptions: that hyperscaler AI capex remains elevated through 2026, and that chip test intensity continues to increase. Both carry bear case vulnerabilities.

If major cloud providers slow AI infrastructure investment after a period of front-loaded spending, GPU and HBM manufacturing volumes could plateau or contract. This would directly reduce ATE order volume in the segment where TER's bull case is most concentrated. Separately, if chipmakers achieve test efficiency improvements (shortening test time through better algorithms or test parallelization), the revenue-per-chip tailwind for Teradyne weakens even if chip volumes continue to grow.

Neither scenario is certain, but both are analytically plausible and receive insufficient attention in bullish TER analyses.

Risk #3: Universal Robots Competitive Pressure

Universal Robots faces intensifying competition as the cobot market matures. ABB Robotics, Fanuc, and Doosan Robotics have all expanded their collaborative robot product lines, eroding UR's first-mover advantages in certain market segments. Newer entrants with lower-cost platforms add further pricing pressure.

If UR loses market share or if global industrial capex recovery stalls due to weak manufacturing demand in Europe and China, the robotics segment could remain a drag on TER's overall performance even if semiconductor test recovers. A scenario where Semiconductor Test rebounds but Industrial Automation stays flat would limit the total revenue upside the bull case requires.

Risk #4: Apple Customer Concentration

Apple's outsized share of TER's Semiconductor Test revenue represents a concentrated customer risk. If Apple changes test processes, brings certain capabilities in-house, diversifies its ATE supplier base, or reduces chip complexity in a product generation, TER faces a revenue headwind that would be difficult to replace quickly. Apple has historically represented a disproportionately large portion of TER's annual ATE revenue. Industry estimates suggest this exposure is significant enough that Apple-specific decisions can move TER's total revenue by several percentage points. This concentration warrants treatment as a real tail risk rather than a remote one.

Risk #5: Valuation and Multiple Compression

TER trades at a premium valuation relative to its own historical average, reflecting market expectations for an earnings recovery. If those expectations disappoint, TER faces a double-bear scenario: earnings estimates are cut (reducing the EPS denominator), and simultaneously, investors apply a lower multiple to those reduced earnings. The combination can produce stock price declines that exceed the percentage decline in earnings alone.

In a downcycle year, TER's P/E multiple has historically compressed to 20–25x forward earnings or below. Applied to a bear case EPS of $3.00–3.50 per share, this yields a price target in the $65–$80 range.

Teradyne Valuation: Is TER Stock Cheap or Expensive?

Teradyne trades at a price-to-earnings ratio (P/E), a measure of how much investors are paying per dollar of a company's earnings (a higher P/E signals higher growth expectations), that carries a material premium relative to its own historical trough valuations, reflecting recovery expectations priced into the stock heading into 2026.

TER's Current and Historical P/E Range

Table 3: Teradyne Valuation Framework

Data as of mid-2025. Verify current figures from MarketBeat, TipRanks, or FactSet before making any investment decision.

TER has historically commanded a premium P/E during upcycle phases because of its market leadership in SoC test, its high-margin software-intensive test platform, and the secular growth positioning of both its ATE and cobot businesses. During downcycle years, that premium compresses as earnings visibility falls and investors apply lower multiples to uncertain near-term EPS trajectories.

Peer Valuation Comparison

Relative to peers, TER's valuation context is informative. Advantest Corporation (TYO: 6857) trades at a comparable forward P/E range, reflecting its own AI/HBM test exposure and recovery trajectory. KLA Corporation (NASDAQ: KLAC), a semiconductor process control equipment peer, has historically traded at a somewhat lower forward P/E than TER, reflecting KLA's more recurring revenue model versus TER's equipment-sale-weighted revenue structure.

The bull case valuation implication: if TER delivers strong earnings growth from AI test demand and UR recovery, the market may reward it with P/E multiple expansion on top of earnings growth. This re-rating dynamic (where the market assigns a higher multiple as growth confidence increases) is a key amplifier of bull case price target upside.

The bear case valuation implication: if 2026 earnings disappoint due to cycle timing miss or AI capex slowdown, TER faces a double compression. Earnings estimates are cut, reducing the EPS base. Investors simultaneously apply a lower multiple. The combined effect can produce stock price declines that materially exceed the percentage earnings miss.

What Wall Street Analysts Are Saying About TER Stock

Wall Street's consensus 12-month price target for Teradyne sits near $105–$125 as of mid-2025, with the majority of covering analysts rating TER Buy or equivalent, based on aggregated data tracked by TipRanks and MarketBeat (verify current figures from TipRanks TER analyst consensus data before acting on any information in this article).

Table 4: Teradyne Analyst Consensus Summary

Data sourced from publicly available analyst coverage. Verify current ratings and targets at TipRanks or MarketBeat before making any investment decision. Analyst targets change frequently.

Wall Street consensus targets typically reflect analysts' base case scenarios. They do not fully capture the upside potential of the bull case or the severity of the bear case risk factors outlined above. Consensus estimates carry positive bias structurally. Analysts as a group tend toward Buy ratings and optimistic targets, and investors should calibrate this data against the bear risks identified in this analysis rather than treating the consensus target as a ceiling or floor.

Based on available consensus estimates, analysts project FY2025 EPS in the range of $3.00–3.50 per share (non-GAAP adjusted), recovering from the 2023–2024 trough. For FY2026, consensus projects EPS in the range of $4.50–5.50 per share. The consensus FY2026 revenue estimate sits near $3.0–3.3 billion. These estimates form the base case row in the scenario summary table below.

Teradyne's Competitive Position: How TER Stacks Up Against Advantest

Teradyne competes most directly in the ATE market against Advantest Corporation (TYO: 6857), a Tokyo-based manufacturer whose strength in memory test equipment makes it both a market peer and a source of concentrated bear case risk.

ATE Market: Where TER Leads and Where Advantest Competes

Table 5: Teradyne vs. Advantest Comparison

Teradyne holds the leading global market share in SoC automated test equipment. The memory test market, including HBM, is more contested. Advantest has been gaining share in HBM test as AI chip production scales, capturing demand that the TER bull case assumes will flow to Teradyne. This competitive dynamic is the most specific and analytically underappreciated bear risk in TER's AI testing narrative.

In the broader competitive landscape, Keysight Technologies (NASDAQ: KEYS) operates in adjacent electronic measurement and test instrument markets but does not compete directly in semiconductor ATE. Within the cobot market, Universal Robots' primary competitors include ABB Robotics, Fanuc, and Doosan Robotics, among others entering as the market matures.

Teradyne's Capital Return Program

Teradyne pays a quarterly cash dividend funded by free cash flow. The current dividend rate is approximately $0.12 per share per quarter (verify the exact current rate from Teradyne SEC EDGAR filings before relying on this figure). On an annualized basis, this represents approximately $0.48 per share.

Teradyne also maintains an active share repurchase program authorized by its board. Buybacks reduce share count over time, which increases EPS for remaining shareholders and supports the bull case total return calculation. During strong FCF periods in upcycle years, TER has historically increased buyback activity. In downcycle years, buybacks may slow as FCF compresses along with revenue. This capital return program differentiates TER from many peers that do not offer both dividend and buyback programs.

Teradyne Stock 2026 Scenario Summary: Bull, Base, and Bear Price Targets

The three scenarios for Teradyne stock in 2026 collapse to a single binary question: does the semiconductor upcycle hit consensus timing with AI capex intact and Universal Robots recovering, or does one or more of those assumptions disappoint?

Table 6: 2026 Scenario Summary: Bull, Base, and Bear

Estimates as of mid-2025. These are conditional projections, not guarantees. All figures should be verified and updated at the time of any investment decision. Analyst consensus sits within the base case range.

The wide gap between bull and bear scenarios reflects the binary nature of Teradyne's 2026 outcome. The semiconductor cycle timing is the single most important variable. Investors comfortable with the cyclical risk and confident in AI capex continuity may find the bull case compelling. Those concerned about cycle timing or valuation compression will find the bear case risks substantial and not easily dismissible. Wall Street consensus, sitting in the base case range, reflects neither the full upside of the bull thesis nor the downside severity of the bear scenario.

Verdict: Is Teradyne Stock a Buy, Hold, or Sell for 2026?

Teradyne enters 2026 with wider scenario dispersion than most large-cap technology stocks. The bull and bear cases are not incremental variations. They are materially different outcomes driven by the same core variables: semiconductor cycle timing, AI capex trajectory, and Universal Robots competitive positioning.

The bull case for TER in 2026 is real and grounded. AI chip complexity is increasing. Test intensity is a structural tailwind for ATE. UR's cobot market has long-term secular tailwinds behind it. If these drivers converge with a broad semiconductor upcycle through 2026, TER could reach $135–$160, representing meaningful upside for investors who accept the cyclical exposure.

The bear case is equally grounded. Cycle timing misses have happened before with TER, including in 2023–2024. Advantest is competing aggressively in HBM test. UR faces real competition from ABB, Fanuc, and a growing field of entrants. TER's premium P/E creates double-bear risk if earnings disappoint. Investors who believe the upcycle peaks earlier than the market expects, or that AI capex moderates, should weigh bear case downside to $65–$80 seriously.

The most important variable to watch is semiconductor equipment order trends in Q1–Q2 2026. Order acceleration signals the bull case is on track. Order softness signals the bear case is materializing before it shows up in reported revenue.

Investors who believe AI capex sustains through 2026, the upcycle recovery matches market expectations, and UR begins recovering may find TER compelling near current levels, with a credible path to the $135–$160 bull case range. Investors concerned about cycle timing, Advantest competition in HBM test, or Apple customer concentration may prefer to wait for order flow confirmation before initiating or adding to a position.

Stock predictions are inherently uncertain. These scenarios represent analytical frameworks, not guarantees. The actual outcome depends on conditions that cannot be fully anticipated today.

This article is for informational purposes only and does not constitute financial advice. Investing in stocks involves risk, including the potential loss of principal. Past performance is not indicative of future results. Please consult a licensed financial advisor before making any investment decisions.

Frequently Asked Questions: Teradyne Stock 2026

What does Teradyne do?

Teradyne (NASDAQ: TER) designs and manufactures automated test equipment (ATE) for semiconductor chips and collaborative robots (cobots) for industrial automation. Its Semiconductor Test segment, accounting for roughly 65–70% of revenue, makes the machines that verify chips work before they ship. Its Industrial Automation segment, roughly 20–25% of revenue, is built around Universal Robots, the world's leading cobot manufacturer.

Is Teradyne a good stock to buy for 2026?

Whether TER is a good buy for 2026 depends on which scenario you find more credible. If AI chip test demand accelerates, the upcycle recovery aligns with market expectations, and Universal Robots returns to growth, the bull case implies $135–$160. If cycle timing disappoints or AI capex slows, the bear case implies $65–$80. The verdict section of this analysis provides the full conditional framework for assessing which scenario fits your investment thesis.

Is Teradyne involved in AI?

Teradyne is not an AI chip maker. It is an AI infrastructure beneficiary. TER makes the automated test equipment that validates AI accelerator chips, such as NVIDIA GPUs and High Bandwidth Memory modules, before they leave the factory. As AI chip complexity increases, the amount of test time required per chip grows, directly increasing Teradyne's revenue opportunity. The connection is indirect but structural: AI capex drives chip manufacturing volume, which drives ATE demand, which drives TER revenue.

Does Teradyne pay a dividend?

Yes. Teradyne pays a quarterly cash dividend of approximately $0.12 per share, funded by free cash flow. TER also maintains an active share repurchase program that reduces share count and increases EPS for remaining shareholders. Verify the current dividend rate from TER's most recent earnings press release or SEC filings before relying on this figure, as dividend rates can change.

Who are Teradyne's competitors?

Teradyne's primary ATE competitor is Advantest Corporation (TYO: 6857), a Tokyo-based manufacturer with particular strength in memory and HBM test equipment. Keysight Technologies (NASDAQ: KEYS) is an adjacent competitor in electronic measurement instruments but does not compete directly in semiconductor ATE. In the cobot market, Universal Robots competes against ABB Robotics, Fanuc, Doosan Robotics, and newer market entrants.

What is the Teradyne stock price target for 2026?

Based on the scenario analysis in this article, the bull case price target range is $135–$160, the base case is $105–$125, and the bear case is $65–$80. Wall Street analyst consensus as of mid-2025 sits in the base case range, approximately $105–$125, based on aggregated data from TipRanks and MarketBeat. Consensus targets reflect analysts' base case scenarios and do not capture the full range of bull or bear outcomes.

What are the biggest risks of investing in Teradyne?

The five most material risks for TER in 2026 are:

• Semiconductor cycle timing miss: If the upcycle peaks or delays beyond consensus expectations, 2026 revenue and EPS estimates face downward revision.
• AI capex deceleration: If hyperscaler AI spending plateaus, GPU and HBM demand drops, reducing ATE order volume in TER's highest-growth segment.
• Universal Robots competitive pressure: ABB, Fanuc, Doosan, and newer entrants are intensifying competition in the cobot market, threatening UR's market share and growth trajectory.
• Apple customer concentration: Apple represents a disproportionately large share of TER's ATE revenue. Any reduction in Apple chip test outsourcing would be a meaningful headwind.
• Valuation and multiple compression: TER's premium P/E makes it vulnerable to a double-bear scenario combining earnings estimate cuts with multiple compression.

Why has Teradyne stock been under pressure?

Teradyne's stock declined materially in 2023–2024 because the semiconductor industry entered a pronounced inventory correction. Following elevated chip demand in 2021–2022, manufacturers over-ordered semiconductors. Excess inventory caused chipmakers to cut ATE capex sharply, reducing TER's order book and revenue. Universal Robots simultaneously faced an industrial slowdown. The 2026 forecast depends on how completely the recovery from that correction has unfolded.

What is Teradyne's market cap?

Teradyne's market capitalization was approximately $17–19 billion as of mid-2025. Market cap fluctuates daily with TER's stock price and any changes to diluted share count from buyback activity or employee compensation programs. Verify the current figure at the time of any investment decision.

How does Teradyne make money from AI chips?

Teradyne does not manufacture AI chips. It makes the automated test equipment (ATE) that chipmakers use to verify AI chips work correctly before shipping them. More complex AI chips require longer test routines, increasing the revenue TER earns per chip tested. As NVIDIA GPU and HBM memory production scales, the testing requirement for those chips grows proportionally, making TER a downstream beneficiary of AI chip volume growth without direct exposure to which chips win market share.